colchicine effect on persistent dyspnea in COVID19
Phase 2
Recruiting
- Conditions
- COVID19.U07.1
- Registration Number
- IRCT20200707048047N1
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
history of covid19 infection confirmed with lung lesion in CT scan and/or positive PCR
Exclusion Criteria
history of taking colchicine..history of ipf.non consent
pregnancy
history of allergic reaction to colchicine
immunosuppressive drug consumption
history of chronic dyspnea or dyspnea on exertion due to underlying diseases
non consent in any stage of study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ???? ???? ??? ?? ???? ???? ???? UCSD. Timepoint: Before intervention,1and6months after intervention. Method of measurement: UCSD questionnaire.
- Secondary Outcome Measures
Name Time Method